SCHEMBL29211972

SCHEMBL29211972

CCCCCCCCCCCCCCCCSSCCCCC(OC(C)Cn1cnc2c(N)ncnc21)P(=O)=O

nearest known ligand 0.55

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ CYP3A4 P08684 12/20 0.55
▸ CYP2D6 P10635 7/20 0.53
▸ ADORA2A P29274 1/20 0.47
▸ ADA P00813 4/20 0.46
▸ PDE2A O00408 2/20 0.46
▸ PDE4A P27815 1/20 0.46
▸ PDE4B Q07343 1/20 0.46
▸ PDE4C Q08493 1/20 0.46
▸ PDE4D Q08499 1/20 0.46
▸ KDM4E B2RXH2 1/20 0.46
▸ ALDH1A1 P00352 1/20 0.46
▸ CYP1A2 P05177 1/20 0.46
▸ ALOX15 P16050 1/20 0.46
▸ SMN1; SMN2 Q16637 1/20 0.46
▸ HSD17B10 Q99714 1/20 0.46
▸ TSHR P16473 1/20 0.46
▸ HIF1A Q16665 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29211975 0.98 CYP3A4 (0.55) CYP3A4CYP2D6ADORA2AADAPDE2A
SCHEMBL29287936 0.96 CYP3A4 (0.55) CYP3A4CYP2D6ADORA2AADAPDE2A
SCHEMBL29287914 0.96 CYP3A4 (0.55) CYP3A4CYP2D6ADORA2AADAPDE2A
SCHEMBL28977844 0.93 CYP3A4 (0.61) CYP3A4CYP2D6ADORA2AADAALDH1A1
SCHEMBL28900524 0.88 CYP3A4 (0.61) CYP3A4CYP2D6ADORA2A
SCHEMBL30931874 0.82 CYP3A4 (0.67) CYP3A4CYP2D6ADORA2AALDH1A1
SCHEMBL30931891 0.82 CYP3A4 (0.67) CYP3A4CYP2D6ADORA2AALDH1A1
SCHEMBL29211966 0.82 CYP3A4 (0.67) CYP3A4CYP2D6ADORA2AALDH1A1
SCHEMBL29211967 0.82 CYP3A4 (0.67) CYP3A4CYP2D6ADORA2AALDH1A1
SCHEMBL28977846 0.82 CYP3A4 (0.53) CYP3A4CYP2D6ADORA2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109320553-B Nucleoside reverse transcriptase inhibitors for antiviral use 深圳市塔吉瑞生物医药有限公司 2024-05-14 — — CN disclosed
CN-109320553-A Novel nucleoside reverse transcriptase inhibitors for antiviral use 深圳市塔吉瑞生物医药有限公司 2019-02-12 — — CN disclosed
Send feedback